Human PRKCSH (Glucosidase 2 subunit beta) knockout HEK-293T cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
PRKCSH KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 13 bp deletion in exon 1 and 14 bp deletion in exon 1 and Insertion of the selection cassette in exon 1.
View Alternative Names
80K-H protein, AGE-R2, AGE-binding receptor 2, G19P1, GLU2B_HUMAN, Glucosidase 2 subunit beta, Glucosidase II beta subunit, Glucosidase II subunit beta, Hepatocystin, PCLD, PKCSH, PRKCSH, Protein kinase C substrate 60.1 kDa protein heavy chain, Protein kinase C substrate 80 Kda protein, Protein kinase C substrate 80K-H
- WB
Lab
Western blot - Human PRKCSH (Glucosidase 2 subunit beta) knockout HEK-293T cell lysate (AB257608)
Lane 1 : Wild-type HEK-293T cell lysate (20µg)
Lane 2 : PRKCSH knockout HEK-293T cell lysate (20µg)
Lane 3 : HeLa cell lysate (20µg)
Lane 4 : Daudi cell lysate (20µg)
Lanes 1- 4 : Merged signal (red and green). Green - ab134071 observed at 80 kDa. Red - loading control ab8245 observed at 37 kDa.
ab134071 Anti-Glucosidase 2 subunit beta antibody [EPR8046] was shown to specifically react with PRKCSH in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266770 (knockout cell lysate ab257608) was used. Wild-type and PRKCSH knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab134071 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Glucosidase 2 subunit beta antibody [EPR8046] (<a href='/en-us/products/primary-antibodies/glucosidase-2-subunit-beta-antibody-epr8046-ab134071'>ab134071</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
PRKCSH knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human PRKCSH (Glucosidase 2 subunit beta) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-prkcsh-glucosidase-2-subunit-beta-knockout-hek-293t-cell-line-ab266770'>ab266770</a>)
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
Daudi cell lysate at 20 µg
Predicted band size: 59 kDa
Observed band size: 80 kDa
false
- WB
Lab
Western blot - Human PRKCSH (Glucosidase 2 subunit beta) knockout HEK-293T cell lysate (AB257608)
Lane 1 : Wild-type HEK-293T cell lysate (20µg)
Lane 2 : PRKCSH knockout HEK-293T cell lysate (20µg)
Lane 3 : HeLa cell lysate (20µg)
Lane 4 : Daudi cell lysate (20µg)
Lanes 1- 4 : Merged signal (red and green). Green - ab129098 observed at 80 kDa. Red - loading control ab8245 observed at 37 kDa.
ab129098 Anti-Glucosidase 2 subunit beta antibody [EPR8047] was shown to specifically react with PRKCSH in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266770 (knockout cell lysate ab257608) was used. Wild-type and PRKCSH knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab129098 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 10000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Glucosidase 2 subunit beta antibody [EPR8047] (<a href='/en-us/products/primary-antibodies/glucosidase-2-subunit-beta-antibody-epr8047-ab129098'>ab129098</a>) at 1/10000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
PRKCSH knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human PRKCSH (Glucosidase 2 subunit beta) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-prkcsh-glucosidase-2-subunit-beta-knockout-hek-293t-cell-line-ab266770'>ab266770</a>)
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
Daudi cell lysate at 20 µg
Predicted band size: 59 kDa
Observed band size: 80 kDa
false
- Sanger seq
Unknown
Sanger Sequencing - Human PRKCSH (Glucosidase 2 subunit beta) knockout HEK-293T cell lysate (AB257608)
Allele-2 : 13 bp deletion in exon 1
- Sanger seq
Unknown
Sanger Sequencing - Human PRKCSH (Glucosidase 2 subunit beta) knockout HEK-293T cell lysate (AB257608)
Allele-3 : Insertion of the selection cassette in exon 1
- Sanger seq
Unknown
Sanger Sequencing - Human PRKCSH (Glucosidase 2 subunit beta) knockout HEK-293T cell lysate (AB257608)
Allele-4 : Insertion of the selection cassette in exon 1
- Sanger seq
Unknown
Sanger Sequencing - Human PRKCSH (Glucosidase 2 subunit beta) knockout HEK-293T cell lysate (AB257608)
Allele-1 : 14 bp deletion in exon 1
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Glucosidase 2 subunit beta is associated with protein maturation and quality control within the ER lumen. It is part of the glucosidase II complex which functions to trim glucose residues from N-linked oligosaccharides on nascent glycoproteins facilitating their proper folding and preventing misfolded proteins' accumulation. This activity ensures that only properly folded proteins progress through the secretory pathway while faulty proteins are targeted for degradation. Through these processes glucosidase 2 subunit beta supports cellular homeostasis and protein turnover.
Pathways
Glucosidase 2 subunit beta plays an influential role in the protein processing and ER-associated degradation (ERAD) pathways. The protein operates within these pathways to regulate glycoprotein folding impacting the unfolding protein response (UPR). It interacts with several proteins including calnexin and calreticulin which are key players in the glycoprotein folding process. Moreover the proper function of glucosidase 2 subunit beta in these pathways is necessary for maintaining the cellular stress response ultimately ensuring efficient cell function and survival.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com